Best practices in cardiometabolic trial design: Planning and...
Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.
Newsletters and Deep Dive digital magazine
Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.
Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.
The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.
Antimicrobial resistance (AMR) is a growing global health crisis.
Editor's Picks
Newsletters and Deep Dive
digital magazine